Table of Contents Table of Contents
Previous Page  111 / 1851 Next Page
Information
Show Menu
Previous Page 111 / 1851 Next Page
Page Background

Best Tumor Shrinkage of Patients Enrolled in

Genotype-Matched Trials

P. Bedard et al. AACR 2015

Breast

Colorectal

Lung

Gynecological

Genitourinary

Pancreatobiliary

Upper Aerodigestive

Other

Disease Sites

Genotype

Matched Trials Most Common Mutations

Breast

22

PIK3CA (18)

Colorectal

18

BRAF (8), KRAS (5)

Lung

21

KRAS (11), EGFR (8)

Gynecological

22

KRAS (12), PIK3CA (6)

RECIST v1.1 Overall Response Rate= 20%